Sivik Global Healthcare’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-45,000
Closed -$4.71M 50
2023
Q4
$4.71M Buy
+45,000
New +$4.16M 1.97% 30
2014
Q1
Sell
-35,000
Closed -$2.22M 71
2013
Q4
$2.22M Buy
+35,000
New +$2.05M 1.58% 33

Other funds holding DVA

Sivik Global Healthcare's DVA Position: Q1 2024 in Review

Sivik Global Healthcare sold out of DaVita (DVA) in Q1 2024, closing a stake of 45,000 shares — an estimated $4.71M sold.

Sivik Global Healthcare first reported a position in DVA in Q4 2013 and held it in 2 quarters. The position peaked at $4.71M in Q4 2023. 545 funds tracked by Wall St. Rank hold DVA as of Q1 2024.

  • Sivik Global Healthcare reported no remaining DaVita position as of Q1 2024 after selling out during the quarter.
  • Sivik Global Healthcare sold 45,000 DaVita shares in Q1 2024, an estimated $4.71M.
  • Sivik Global Healthcare first reported a position in DaVita in Q4 2013 and held it in 2 quarters.
  • Sivik Global Healthcare's DaVita position peaked at $4.71M in Q4 2023.
  • 545 funds tracked by Wall St. Rank held DaVita as of Q1 2024.

Based on Sivik Global Healthcare's 13F filing for Q1 2024, filed 1 May 2024.